PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-02-10

Date Title Company
10-Feb-2026 uniQure N.V. (QURE) Investors: Kessler Topaz Meltzer & Check, LLP Announces That the Firm Has Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. and Encourages Investors to Contact the Firm Businesswire
10-Feb-2026 RARE Investors: Kessler Topaz Meltzer & Check, LLP Reminds Investors of April 6, 2026 Deadline in Securities Fraud Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical Inc. Businesswire
10-Feb-2026 Medicare Part B is Not a Plan B ACCESS Newswire
10-Feb-2026 THX Pharma and Biocodex Announce a Strategic Licensing Agreement in Batten, Gaucher and Niemann-Pick Type C Diseases Businesswire
10-Feb-2026 Medincell’s ISS ESG Corporate Rating Upgraded Businesswire
10-Feb-2026 Facet Life Sciences Publishes Second Edition of FDA and Intellectual Property Strategies for Medical Device Technologies Businesswire
10-Feb-2026 Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010 ACCESS Newswire
10-Feb-2026 THX Pharma and Biocodex announce a strategic licensing agreement covering three rare diseases. THX Pharma
10-Feb-2026 SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems SOPHiA GENETICS
10-Feb-2026 AOP Health US, LLC Awarded Pharmaceutical Agreement With Premier, Inc. Businesswire
10-Feb-2026 NinjaOne Expands Platform with IT Asset Management to Reduce Cost and Risk Businesswire
10-Feb-2026 Joe Biehl Named CEO of Healthcare Innovation Catalysts Businesswire
10-Feb-2026 Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026 Businesswire
10-Feb-2026 With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation ACCESS Newswire
10-Feb-2026 The Oxford-Harrington Rare Disease Centre Advances Discovery of Therapies for Friedreich’s Ataxia (FA) The Oxford-Harrington Rare Disease Centre
10-Feb-2026 Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results ACCESS Newswire
10-Feb-2026 Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 Businesswire
10-Feb-2026 HemoSonics’ Quantra Hemostasis System for Obstetric Procedures Named a 2026 Edison Awards Finalist Businesswire
10-Feb-2026 Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial Businesswire
10-Feb-2026 ON24 Celebrates 2025 Winners of the Digital Engagement Excellence Awards Businesswire